HOLLISTON, Mass., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (HBIO) today announced that it will be showcasing its latest product innovations at the Society for Neuroscience (SfN) ...
Using a structured matchmaking framework, the pilot connects university labs with industry research teams through targeted ...
Streamlining production footprint and improving manufacturing efficiency through phased closure of Holliston, MA plant Initiative expected to ...
Life Biosciences will test its gene therapy designed to partially reset a cell’s age and potentially reverse vision loss in ...
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates ...
Harvard Bioscience makes laboratory instruments and devices that support research in areas like drug discovery, therapy development, and preclinical testing. Its core products are used by universities ...
The MarketWatch News Department was not involved in the creation of this content. HOLLISTON, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the "Company" or ...
Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results